Lily Kabarame, BSN, RN, of Dana-Farber Cancer Institute
Congratulations to Lily Kabarame, BSN, RN, recipient of the 2026 New England Regional Black Nurses Association Excellence in Nursing Practice Award. Lily is recognized for her work as an oncology nurse navigator with the @danafarber.bsky.social Lank Center for Genitourinary Oncology.
Why is #colorectalcancer rising in younger adults? Featured in @katiecouric.bsky.social Media, @danafarber.bsky.social’s Dr. Kimmie Ng discusses the top theories researchers are investigating and risk factors you don't want to ignore. #ColorectalCancerAwarenessMonth
➡️ bit.ly/4ujThU7
In a study published in @cp-cancercell.bsky.social, @danafarber.bsky.social researchers led by Dr. David Barbie uncovered why small cell lung cancer can stay largely out of reach of the immune system, even when the cancer cells themselves are vulnerable to immune attack. #SCLC bit.ly/4ucsJnp
Dr. Erica Pimenta of Dana-Farber Cancer Institute
“If the right type of cell is there, maybe we can bolster the immune response. In particular, that immunological aim of the GLP-1 study is exciting to me,” @danafarber.bsky.social’s Dr. Erica Pimenta tells Targeted Oncology about key findings from her liposarcoma research. ➡️ bit.ly/40bFGAs
New research in @natcomms.nature.com by @danafarber.bsky.social’s @mishabeltran.bsky.social and Varadha Balaji Venkadakrishnan, PhD, reveals how prostate cancer becomes resistant to treatment and DNA methylation and EZH2 activity drive neuroendocrine prostate cancer.
➡️ bit.ly/4sk61bg
Judith Agudo, PhD. of Dana-Farber Cancer Institute
New research published by @danafarber.bsky.social’s Judith Agudo, PhD, and colleagues in @nature.com today reveals a new strategy to prevent the metastasis of triple-negative breast cancer.
➡️ bit.ly/4rLuOFj
Cathy Wu, MD, of Dana-Farber Cancer Institute
Cancer Grand Challenges has awarded $25 million to team ILLUMINE, a group of leading scientists around the world including @danafarber.bsky.social’s Dr. Cathy Wu, who will work to unlock the potential of the cancer dark proteome.
bit.ly/4d1AxSV
"LITESPARK-022 is the first adjuvant trial in kidney cancer to show a benefit for a combination versus a PD-1 agent alone." @danafarber.bsky.social’s Toni Choueiri, MD, featured in Fierce Pharma discussing kidney cancer research he presented at #ASCOGU.
➡️ bit.ly/3MTz0nq
"The Cancer No One Can Explain" - Kicking off #ColorectalCancerAwareness month with this great piece in @nautil.us magazine featuring a Q&A about young-onset colorectal cancer with @danafarber.bsky.social’s Dr. Leah Biller.
Read more here: bit.ly/4b4lRju
At #ASCOGU26: @danafarber.bsky.social’s Dr. Brad McGregor provides an update on the STRIKE! clinical trial which looks at short term intensified pembrolizumab and tivozanib for high-risk renal cell carcinoma.
Dr. Alicia Morgans of Dana-Farber Cancer Institute
Research at #ASCOGU: @danafarber.bsky.social’s Dr. Alicia Morgans provides insights from the ARANOTE trial during a poster session. The poster looks at the impact of hospitalizations on health-related quality of life and overall survival in metastatic castration-sensitive prostate cancer.
"The most frightening thing is, we don’t completely understand why these rates are rising in young people without risk factors” - @danafarber.bsky.social’s Dr. Kimmie Ng speaks with 7News Boston about the rising rate of young-onset colorectal cancer.
➡️ bit.ly/4sf4bZk
Keene Abbott, PhD, of Dana-Farber Cancer Institute
Congratulations to Keene Abbott, PhD, of @danafarbernews.bsky.social and @bostonchildrens.bsky.social who received the 2026 Harold M. Weintraub Graduate Student Award for his outstanding achievement during graduate studies in the biological sciences.
Eli Van Allen, MD, of Dana-Farber Cancer Institute
Reimagining Cancer Research and Care in the Age of Artificial Intelligence: @danafarbernews.bsky.social’s Eli Van Allen, MD, delivers this keynote presentation at #ASCOGU26 today at 2:15pm PT/11:15am ET.
Xiao Wei, MD, of Dana-Farber Cancer Institute
At today's #ASCOGU poster session: @danafarbernews.bsky.social’s Xiao Wei, MD, presents on the effectiveness of systemic therapies after Lu-PSMA-617 treatment in patients with metastatic castration-resistant prostate cancer.
Xin Zhou, PhD, of Dana-Farber Cancer Institute
Congrats to @danafarbernews.bsky.social’s Xin Zhou, PhD, recipient of a 2026 Damon Runyon-Rachleff Innovation Award for "Extracellular reprogramming of kinase signaling pathways.” The award supports ideas with potential to impact the prevention, diagnosis, or treatment of cancer.
➡️ bit.ly/4rA75Il
Expert analysis: Dr. Michael Serzan and Dr. Emre Yekedüz, both of @danafarbernews.bsky.social, preview the practice-changing data they expect this week at #ASCOGU.
Read more in @curetoday.bsky.social: bit.ly/46thzk5
Sabrina Camp, Kevin Bi and Eli Van Allen, MD, of Dana-Farber Cancer Institute
Research in Science Advances by @danafarbernews.bsky.social’s Sabrina Camp, Kevin Bi and Eli Van Allen, MD, revealed loss of the gene BAP1 activates a tumor-intrinsic interferon signaling program, highlighting immune evasion pathways as potential treatment targets. @broadinstitute.org bit.ly/4cEOFBl
Amy Lee, PhD, and Max Fels, PhD, of Dana-Farber Cancer Institute
New research by @danafarbernews.bsky.social’s Amy Lee, PhD, and @mfels.bsky.social in @cp-cell.bsky.social reveals that giant DNA viruses encode a distinct & functional IF4F translation-initiation complex to drive protein synthesis, blurring the line between living cells and viruses. bit.ly/4rS3Uew
Sonomi Yamaguchi of Dana-Farber Cancer Institute
New research featured in @nature.com from Sonomi Yamaguchi of @danafarbernews.bsky.social’s @kranzuschlab.bsky.social discovers “p3diT” as a nucleotide immune signal in bacteria and suggests similar signals may function as negative regulators in human immunity.
Read more: bit.ly/3MTjLL6
Transatlantic Exchange
Targeting the RAS Oncogene in Cancer – a keynote address presented by @danafarbernews.bsky.social’s Alice Shaw, MD, PhD, at this year’s Transatlantic Exchange hosted by Dana-Farber with @gustaveroussy.fr, sponsored by Servier and presented by Medscape Medical Affairs. Register today: bit.ly/461YzZS
Cancer care and AI: Dr. Eli Van Allen will deliver the #ASCOGU26 keynote address on “Reimagining Cancer Research and Care in the AI Age.”
Read more in The @ascopost.bsky.social ➡️ bit.ly/4rQChTp
Featured on @boston25news.com, Dr. Kimmie Ng of @danafarbernews.bsky.social discusses colorectal cancer risks in younger adults following the sad news of the death of “Dawson's Creek” actor James Van Der Beek.
➡️ bit.ly/4qBnIlE
Transatlantic Exchange
Agenda for the 5th annual Transatlantic Exchange: epigenetic therapies; microbiome-driven immunity; and cellular pathway reprogramming. Join experts from @danafarbernews.bsky.social and @gustaveroussy.fr at the 1-day event in Boston dedicated to frontiers in cancer drug research.
➡️ bit.ly/4qruni1
A new study led by @danafarbernews.bsky.social’s Dr. Kai Wucherpfennig and colleagues shows that an injection of a genetically modified virus that selectively infects and destroys cancer cells can recruit immune cells to penetrate and persist deep within brain tumors.
➡️ bit.ly/4atTuee
Donate blood and platelets today!
Donations of whole blood and platelets are urgently needed by Kraft Family Blood Donor Center due to the national shortage caused by winter storm and flight disruptions. Make an appt to support @danafarbernews.bsky.social and Brigham & Women’s Hospital patients at 617-632-3206.
➡️ bit.ly/4a3ssu2
The Center for Global Health at Dana-Farber Cancer Institute is launching the first colorectal cancer screening program in Central Asia, partnering with Uzbekistan's Ministry of Health and National Cancer Center.
The Center for Global Health at @danafarbernews.bsky.social is excited to launch the first colorectal cancer screening program in Central Asia, partnering with Uzbekistan's Ministry of Health and National Cancer Center.
Read more here: bit.ly/4bzLivg
Corey Culter, MD, MPH, of Dana-Farber Cancer Institute
Congratulations to @danafarber.bsky.social's Corey Culter, MD, MPH, who has been named to the 2026 Class of the American Society of Transplantation and Cellular Therapy (ASTCT) Fellows Program for his impact on hematopoietic stem cell transplantation and cellular therapy.
Dr. Kimmie Ng of Dana-Farber Cancer Institute
The @washingtonpost.com recognized @danafarber.bsky.social's Dr. Kimmie Ng for her work in young-onset colorectal cancer. Dr. Ng is part of the 'Post Next 50,' the newspaper's annual look at 50 people shaping society in 2026.
Read more here: bit.ly/4kqFWob
Vinayak Venkataraman, MD, of Dana-Farber Cancer Institute
ICYMI: Research by @danafarber.bsky.social's Vinayak Venkataraman, MD, in the Journal of Adolescent and Young Adult Oncology confirmed that #sarcoma and its treatment greatly disrupted the lives of #AYA patients – yet earlier introduction of support services may ease some challenges. bit.ly/3ZRpROT
